Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: a single center analysis and review of the literature.
Strobel
Eva-Susanne
ES
Bauchmüller
Kris
K
Ihorst
Gabriele
G
Engelhardt
Monika
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D002330:Carmustine / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015994:Incidence; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000628:therapy*; D008297:Male; D008558:Melphalan / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D011034:Podophyllotoxin / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D012307:Risk Factors; D013280:Stomatitis / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology* / Q000473:pathology; D016019:Survival Analysis; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous
D003561:Cytarabine; D011034:Podophyllotoxin; D008558:Melphalan; D002330:Carmustine